Physician profile
Roberto Gines
NPI 1619992153
$452.74
in general payments reported to CMS, 2019-2025
10 companies · $77.60 in 2025
The $77.60 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.75 · 2021: $48.94 · 2022: $117 · 2023: $132 · 2024: $65.92 · 2025: $77.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $275.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $127.78 | 2022-2023 | Brilinta |
| Pfizer INC. | $106.77 | 2021-2025 | |
| Octapharma USA, INC. | $45.78 | 2024 | Balfaxar |
| Ucb, INC. | $39.32 | 2023 | Nayzilam |
| Janssen Pharmaceuticals, INC | $34.10 | 2021-2022 | |
| Chiesi USA, INC. | $26.04 | 2021-2022 | |
| Melinta Therapeutics, LLC | $23.44 | 2025 | Kimyrsa, Rezzayo |
| Lundbeck LLC | $20.35 | 2022 | |
| Alexion Pharmaceuticals, INC. | $17.41 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Gines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.